Edition:
India

Fibrocell Science Inc (FCSC.OQ)

FCSC.OQ on NASDAQ Stock Exchange Capital Market

0.75USD
12 Jan 2018
Change (% chg)

-- (--)
Prev Close
$0.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
68,875
52-wk High
$4.59
52-wk Low
$0.61

Chart for

About

Fibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either... (more)

Overall

Beta: 0.62
Market Cap(Mil.): $43.12
Shares Outstanding(Mil.): 14.72
Dividend: --
Yield (%): --

Financials

BRIEF-Fibrocell Science Says Expects IND Filing Of FCX-013 In Q1 2018

* FIBROCELL SCIENCE INC SAYS EXPECTS IND FILING OF FCX-013 IN Q1 2018 AND INITIATE SAFETY CLINICAL TRIAL IN 2018 - SEC FILING Source text: (http://bit.ly/2EaJQ01) Further company coverage:

29 Dec 2017

BRIEF-Fibrocell Science Q3 loss per share $‍0.02​

* Fibrocell reports third quarter 2017 financial results and recent highlights

13 Nov 2017

BRIEF-Fibrocell Science files for common stock offering of up to $23 mln

* Fibrocell Science Inc files for common stock offering of up to $23 million - SEC filing‍​ Source text: (http://bit.ly/2AoC3tG) Further company coverage:

07 Nov 2017

BRIEF-Fibrocell reports qtrly loss per share $0.97

* Fibrocell reports second quarter 2017 financial results and recent highlights

09 Aug 2017

Earnings vs. Estimates